The Discounted Cash Flow (DCF) valuation of PuraPharm Corp Ltd (1498.HK) is 0.56 HKD. With the latest stock price at 0.46 HKD, the upside of PuraPharm Corp Ltd based on DCF is 22.4%.
Based on the latest price of 0.46 HKD and our DCF valuation, PuraPharm Corp Ltd (1498.HK) is a buy. Buying 1498.HK stocks now will result in a potential gain of 22.4%.
Range | Selected | |
WACC / Discount Rate | 5.3% - 7.6% | 6.5% |
Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
Fair Price | (0.03) - 3.07 | 0.56 |
Upside | -105.6% - 567.2% | 22.4% |
(HKD in millions) | Projections | |||||
12-2024 | 12-2025 | 12-2026 | 12-2027 | 12-2028 | 12-2029 | |
Revenue | 382 | 399 | 411 | 427 | 444 | 464 |
% Growth | 6% | 4% | 3% | 4% | 4% | 5% |
Cost of goods sold | (178) | (176) | (172) | (170) | (168) | (167) |
% of Revenue | 46% | 44% | 42% | 40% | 38% | 36% |
Selling, G&A expenses | (223) | (233) | (240) | (250) | (260) | (271) |
% of Revenue | 58% | 58% | 58% | 58% | 58% | 58% |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
% of Revenue | 0% | 0% | 0% | 0% | 0% | 0% |
Net interest & other expenses | (10) | (11) | (11) | (11) | (12) | (12) |
% of Revenue | 3% | 3% | 3% | 3% | 3% | 3% |
Tax expense | (6) | 1 | 1 | 0 | (0) | (1) |
Tax rate | 22% | 4% | 4% | 4% | 4% | 4% |
Net profit | (35) | (20) | (12) | (4) | 4 | 13 |
% Margin | -9% | -5% | -3% | -1% | 1% | 3% |